MedPath

Neurally Adjusted Ventilatory Assist (NAVA) in Pediatric Patients

Not Applicable
Completed
Conditions
Ventilation
Interventions
Device: Neurally adjusted ventilatory assist, i-Servo, Maquet Nordic (Solna, Sweden)
Device: Control (PC- or PRVC- ventilation), i-Servo, Maquet Nordic (Solna, Sweden)
Registration Number
NCT01056939
Lead Sponsor
University of Oulu
Brief Summary

The purpose of this study is to find out if NAVA-technology is better in detecting patients own inspiratory efforts during mechanical ventilation than currently used flow-triggering in PRVC (pressure regulated volume controlled) ventilation, and if NAVA gives real benefits for patients or not.

The investigators study hypothesis is that NAVA-technology can detect spontaneous inspiration more accurately than currently used methods, and thus will lead to more smooth adaptation to mechanical ventilation in pediatric patients. The investigators expect this to decrease the time of ventilatory support needed.

Detailed Description

Asynchrony means that the timing of support given by ventilator is different from patients own breathing pattern. Asynchrony during ventilatory care may increase the risk for complications, make the weaning more difficult and may affect the survival rates.

In our study we randomly treat pediatric patients needing ventilatory support with neurally adjusted ventilatory assist and pressure controlled or PRVC-ventilation. We are willing to find out if there are any special benefits for patients with each treatment mode.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
170
Inclusion Criteria
  • All children from term newborn (37+0 gestational week) to 16-year-old needing ventilatory care at least 30 minutes
Exclusion Criteria
  • Any condition that prevents feeding tube positioning. Critical ventilatory or perfusion problems.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
NAVANeurally adjusted ventilatory assist, i-Servo, Maquet Nordic (Solna, Sweden)Children randomised in this arm will be treated with neurally adjusted ventilatory assist
ControlControl (PC- or PRVC- ventilation), i-Servo, Maquet Nordic (Solna, Sweden)Patients randomized to control group will be treated with pressure controlled ventilation (PC) when they are newborns and older children in this group will be treated with pressure regulated volume controlled (PRVC) ventilation.
Primary Outcome Measures
NameTimeMethod
Primary outcome is the duration of mechanical ventilation30minutes-3weeks
Secondary Outcome Measures
NameTimeMethod
Amount of sedative medication needed30minutes-3weeks

Trial Locations

Locations (1)

University Hospital of Oulu

🇫🇮

Oulu, Finland

© Copyright 2025. All Rights Reserved by MedPath